Allspring Global Investments Holdings LLC Sells 483,817 Shares of LivaNova PLC (NASDAQ:LIVN)

Allspring Global Investments Holdings LLC cut its position in LivaNova PLC (NASDAQ:LIVN - Free Report) by 62.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 288,315 shares of the company's stock after selling 483,817 shares during the period. Allspring Global Investments Holdings LLC owned about 0.53% of LivaNova worth $11,325,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Russell Investments Group Ltd. grew its position in LivaNova by 17.1% in the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after purchasing an additional 219 shares in the last quarter. Summit Investment Advisors Inc. grew its position in LivaNova by 1.7% in the fourth quarter. Summit Investment Advisors Inc. now owns 16,846 shares of the company's stock valued at $780,000 after purchasing an additional 289 shares in the last quarter. Central Pacific Bank Trust Division grew its position in LivaNova by 7.0% in the first quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock valued at $173,000 after purchasing an additional 290 shares in the last quarter. Xponance Inc. grew its position in LivaNova by 6.1% in the fourth quarter. Xponance Inc. now owns 7,762 shares of the company's stock valued at $359,000 after purchasing an additional 445 shares in the last quarter. Finally, Mariner LLC grew its position in LivaNova by 8.4% in the fourth quarter. Mariner LLC now owns 5,741 shares of the company's stock valued at $266,000 after purchasing an additional 446 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

LivaNova Price Performance

Shares of LivaNova stock traded down $0.55 during midday trading on Monday, hitting $45.58. 502,649 shares of the company traded hands, compared to its average volume of 637,772. The stock has a market cap of $2.49 billion, a price-to-earnings ratio of -11.14 and a beta of 0.90. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.37 and a current ratio of 1.58. The firm's fifty day moving average price is $43.80 and its 200-day moving average price is $43.26. LivaNova PLC has a 12 month low of $32.48 and a 12 month high of $57.35.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Robert W. Baird lifted their price objective on shares of LivaNova from $55.00 to $61.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Wolfe Research upgraded shares of LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price for the company in a research note on Tuesday, May 20th. Needham & Company LLC reiterated a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a research note on Tuesday, May 13th. Barclays dropped their price objective on shares of LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Finally, Wall Street Zen cut shares of LivaNova from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 8th. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $59.29.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.